SEC Form 4 · accession 0001209191-15-049641
Cascadian Therapeutics, Inc. · CASC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Diana Hausman
Officer — Chief Medical Officer
Period of report
Jun 1, 2015
Accepted (ET)
Jun 3, 2015 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001412067
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 1, 2015 | P | 5,747 | $4.65 | A | 5,747 | I | By spouse |
Table II — derivative securities
No Table II lines on this filing.